Preoperative Neutrophil/Lymphocyte Ratio Predicts Overall Survival and Extravesical Disease in Patients Undergoing Radical Cystectomy
- 1 August 2013
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 27 (8) , 1046-1050
Abstract
Purpose: To evaluate if hematologic parameters and inflammatory markers could predict extravesical tumor and overall survival after radical cystectomy for patients with recurrent high grade T1 or muscle-invasive bladder cancer. Patients and Methods: A total of 68 consecutive cases of radical cystectomy performed with curative intent at our institution between April 2005 and October 2011 with preoperative hematologic parameters are included in this analysis. We evaluated preoperative characteristics with univariable and multivariate Cox proportional hazard ratios to assist in risk stratification for overall survival. Relative risk (RR) ratios and 95% confidence intervals (CI) were created. We also identified factors associated with extravesical tumor extension with logistic regression analysis. Results: Median overall survival in the total cohort was 25 months (95% CI 13–61). In multivariate analysis, neutrophil/lymphocyte ratio 3/4 (RR 7.97, 95% CI 3.16–24.83), and lymph node positive disease (RR 2.62, 95% CI 1.26–5.46) predicted overall survival. These were statistically significant for cancer-specific survival as well. Both elevated neutrophil/lymphocyte ratio (RR 3.18, 95% CI 1.09–9.79) and hypoalbuminemia (RR 3.72, 95% CI 1.12–15.00) were associated with risk for extravesical disease. Conclusions: Serum neutrophil/lymphocyte ratio and hypoalbuminemia predict overall and cancer-specific survival in patients undergoing radical cystectomy for muscle-invasive bladder cancer. These parameters also predict risk for extravesical disease. These could be combined with other established preoperative parameters to improve risk stratification and preoperative counseling.Keywords
This publication has 23 references indexed in Scilit:
- Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical CystectomyUrology, 2012
- Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 StatusJournal of Clinical Oncology, 2011
- Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancerJournal of Surgical Oncology, 2011
- Nonsteroidal Antiinflammatory Drugs and Bladder Cancer: A Pooled AnalysisAmerican Journal of Epidemiology, 2011
- Effect of Preoperative Nutritional Deficiency on Mortality After Radical Cystectomy for Bladder CancerJournal of Urology, 2011
- Contemporary use of perioperative cisplatin‐based chemotherapy in patients with muscle‐invasive bladder cancerCancer, 2010
- Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancerRadiation Oncology, 2010
- Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years LaterJournal of Urology, 2008
- C‐reactive protein level predicts prognosis in patients with muscle‐invasive bladder cancer treated with chemoradiotherapyBJU International, 2008
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003